GenoCure.AI is an AI-native precision oncology platform leveraging multimodal analysis of both RNA and DNA to guide personalized cancer care. Unlike others focused solely on static mutations, our platform integrates transcriptomic signals to uncover resistance patterns and therapy opportunities. CDS-exempt and cloud-native, GenoCure delivers clinically actionable insights for complex cases—helping oncologists go beyond standard gene panels to make better-informed treatment decisions.